Predictive immunohistochemical features for tumour response to chemoradiotherapy in rectal cancer.
Eiji ShintoJ OmataA SikinaA SekizawaY KajiwaraK HayashiY HashiguchiK HaseH UenoPublished in: BJS open (2020)
Assessment of CD133, COX-2 and CD8 could be useful in predicting a good response to preoperative CRT in patients with lower rectal cancer undergoing neoadjuvant therapy. Further studies are needed to validate the results in larger cohorts and investigate a survival benefit.